Frontlight ResearchEarly access
Active, not recruitingPhase 2
PiSCATIN - Simvastatin for the treatment of primary sclerosing cholangitis (PSC) - a randomized double-blind, placebo-controlled multicenter study
Key facts
- Who runs it
- Karolinska University Hospital
- Where
- Sweden12 sites in 1 countryChoose a country to see its sites
- Status
- Active, not recruiting
- Phase
- Phase 2
- People taking part
- 560 people, planned
- Started
- 4 May 2020
- Expected to end
- 30 Sept 2030
- Type of study
- Interventional
- Record updated
- 9 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Patients with a cholangiographically verified PSC and/or liverbiopsy with and without IBD (patients with a present autoimmun hepatit and small duct PSC can be included)
- Men and women ≥18 years but ≤75 years
- Patient has given written consent to participate in the study
- MR/MRCP within 4 months
- Coloscopy within 24 months if the patient has a known IBD
- Female of childbearing potential must agree to use a highly efficient method of contraception during the study participation
Who cannot take part
- Patients on waiting list for transplantation
- Previous varices bleeding secondary to end stage liver disease
- Previous cholangiocarcinoma
- Patients who have been taking any statin medication during the last 3 months
- Patients with severe liver failure ≥ Child B 9 points
- Transplanted patients
- Patients with secondary sclerosing cholangitis
- Intolerance to statins
- Pregnancy and breastfeeding
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Does treatment with simvastatin prolong survival free from bile duct cancer, variceal bleeding and transplantation in PSC?
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 9 January 2026